Catalyst Wire Dossier Catalyst Wire Dossier

MATZIM LA

DILTIAZEM HYDROCHLORIDE · Actavis Pharma, Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for MATZIM LA, covering 2010-03-15 to 2026-04-09. Get the full timeline:

Most recent: FDA Approved: MATZIM LA — Supplemental Application (Actavis Pharma, Inc.)

See pricing